Physician

Lee T Tran, MD

According to 2025 Medicare claims, Lee Tran, MD (NPI: 1548403496) practices ophthalmology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is HOUSTON RETINA ASSOCIATES PA (NPI: 1942347570; TIN: 010699322) and primary practice location at 77598-4240. Tran is affiliated with the CHI Saint Joseph Health Partners (ACO ID: A4638), participating under the MSSP model.

Tran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 517 traditional Medicare patients, billed 61,542 HCPCS/CPT codes, and received $2,367,545 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,345 prescription claims across 376 beneficiaries totaling $146,806 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 32 records totaling $1,252. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $798,344 to $2,367,545. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $96,946 and ending at $146,806. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.4M2015 Medicare payment: $798,344 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $938,275 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $885,345 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,096,198 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,462,738 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,377,515 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,610,900 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,721,931 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,922,787 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,367,545 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154417,027$798,344
20164999,189$938,275
20175339,657$885,345
20185459,575$1,096,198
20195548,371$1,462,738
20204856,582$1,377,515
20214797,011$1,610,900
20224898,567$1,721,931
202350831,351$1,922,787
202451761,542$2,367,545

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$126K$252K2015 Drug cost: $96,946 (USD; Tot_Drug_Cst)2016 Drug cost: $214,555 (USD; Tot_Drug_Cst)2017 Drug cost: $149,940 (USD; Tot_Drug_Cst)2018 Drug cost: $143,014 (USD; Tot_Drug_Cst)2019 Drug cost: $117,180 (USD; Tot_Drug_Cst)2020 Drug cost: $187,793 (USD; Tot_Drug_Cst)2021 Drug cost: $206,896 (USD; Tot_Drug_Cst)2022 Drug cost: $252,299 (USD; Tot_Drug_Cst)2023 Drug cost: $214,479 (USD; Tot_Drug_Cst)2024 Drug cost: $146,806 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015129446$96,946
2016151576$214,555
2017175667$149,940
2018191784$143,014
2019239899$117,180
2020234976$187,793
20212761,077$206,896
20223121,132$252,299
20233201,127$214,479
20243761,345$146,806

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2141,008$108
92014Established patient complete exam of visual system4181,305$93
92134Imaging of retina5021,625$31
J2777Injection, faricimab-svoa, 0.1 mg15252,560$28
92201Extended exam of the back part of the eye with retinal drawing250393$19

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept22616$51,906
RestasisCyclosporine441,830$36,472
Restasis MultidoseCyclosporine18534$11,164
Prednisolone AcetatePrednisolone Acetate2198,436$7,249
LumiganBimatoprost14808$6,782

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.32$1,252Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Lee T. Tran, MD?

Tedicare shows public-source Medicare data for Lee T. Tran, MD (NPI 1548403496), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lee T. Tran, MD have ACO affiliation data?

Lee T. Tran, MD is shown with ACO affiliation data for CHI Saint Joseph Health Partners (MSSP, ACO ID A4638).

What billing organization is linked to Lee T. Tran, MD?

Lee T. Tran, MD is linked to HOUSTON RETINA ASSOCIATES PA (billing NPI 1942347570) in the available physician profile data.

Does Lee T. Tran, MD have Open Payments data?

Lee T. Tran, MD has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.